Débora Barton

840 citations
9 papers · 517 · 1 hit paper · h-index 6

Impact in

  • Oncology top 10%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers
    • Cancer Treatment and Pharmacology
    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics

Papers in

    • CAR-T cell therapy research 3
    • Cancer Treatment and Pharmacology 2
    • Breast Cancer Treatment Studies 2

Débora Barton

9 papers receiving 513 citations

Débora Barton's Hit Papers

CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial 2025 · 157 citations
1570Years since publication50100150

Peers

Débora Barton
Comparison fields: 5 of 43
  • Oncology 183
  • Cancer Research 106
  • Pulmonary and Respiratory Medicine 170
  • Immunology 70
  • Biomaterials 17
Replace Robyn R. Young with:
Robyn R. Young United States
Shyam Kalavar United States
Anna Turletti Italy
Maryam Razaq United Kingdom
M. Pulido France
Liliana Ascione Italy
Jianting Feng China
Tamar Peretz Switzerland
Fernanda Damian United States
Corinne Maurice‐Dror Canada
Débora Barton relative to Robyn R. Young United States Robyn R. Young's profile →
Citations per field
00.5×2×4×6.4×
Robyn R. Young · 1×
Citations per year

Countries citing papers authored by Débora Barton

Since Specialization
Citations

This map shows the geographic impact of Débora Barton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Débora Barton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Débora Barton more than expected).

Fields of papers citing papers by Débora Barton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Débora Barton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Débora Barton. The network helps show where Débora Barton may publish in the future.

Co-authors

The 25 scholars most cited alongside Débora Barton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Débora Barton Line = papers co-authored together Débora Barton links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
Hit paper breakdown →
2025157
2 2015126
3 2018110
4 201650
5 201634
6 201530
7 20065
8 20214
9 20221

About Débora Barton

Débora Barton is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Hematology and Nuclear Energy and Engineering, having authored 9 papers that have together received 517 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (3 papers), CAR-T cell therapy research (3 papers), Breast Cancer Treatment Studies (2 papers), Cancer Treatment and Pharmacology (2 papers) and Hematopoietic Stem Cell Transplantation (1 paper). The work is most often cited by research in Oncology (183 citations), Cancer Research (106 citations), Pulmonary and Respiratory Medicine (170 citations), Immunology (70 citations) and Biomaterials (17 citations). Débora Barton has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Adam Brufsky, PierFranco Conte, Nadia Harbeck, Javier Cortés, Denise Aysel Yardley, Stefan Glück, Joyce O’Shaughnessy, Haythem Y. Ali, Mikhail I. Shtivelband and Robyn R. Young. Their work appears in journals such as Blood, The Lancet Oncology, Annals of Oncology, Cytotherapy and European Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact